医薬品原薬 (API) の世界市場の将来予測
Global Active Pharmaceutical Ingredients Market Forecast 2019-2027
|出版日||ページ情報||英文 153 Pages
|医薬品原薬 (API) の世界市場の将来予測 Global Active Pharmaceutical Ingredients Market Forecast 2019-2027|
|出版日: 2019年04月08日||ページ情報: 英文 153 Pages||
当レポートでは、世界の医薬品原薬 (API) 市場の将来展望について分析し、主な市場促進・抑制要因や、全体的な市場動向の見通し (今後9年間分)、種類別・生産目的別・合成方法別・用途別および地域別の詳細動向、市場の競争環境および求心力、各国政府の関連規制・政策、主要企業のプロファイルなどを調査しております。
There are various chemicals that are contained within the drugs and the portion that catalyzes in treating the condition, i.e., the active part is known as the 'active pharmaceutical ingredients' or API. The growing rate of geriatric population and the subsequent rising incidences of age-related diseases are driving the demand of the active pharmaceutical ingredients in the market.
The global active pharmaceutical ingredients (APIs) market is anticipated to generate revenue of $XX billion by 2027 and is expected to proliferate at a CAGR of 6.10% through the forecasting years of 2019-2027.
As mentioned earlier, the growing demand for drugs to treat the aging population will primarily boost market growth during the forecast period. The applications of active pharmaceutical ingredients and APIs synthesis market are very versatile. The cardiovascular disease, oncology, CNS and neurological disorders, orthopedic disorders, endocrinology, pulmonology, gastrointestinal disorders, nephrology, ophthalmology, and other application employ the APIs for their respective treatment.
The high amount of investment and production cost and aggressive competition among API manufacturers are the major factors hindering the active pharmaceutical ingredients market. API manufacture requires sophisticated infrastructure, and thus it is capital intensive. API giants are employing strategies to distinguish themselves, which is further escalating the competition in the market.
The global active pharmaceutical ingredients market has been segmented on the basis of four major geographical regions, namely, North America, Asia Pacific, Europe, and the remaining countries collectively forming the Rest of World regional segment.
The active pharmaceutical ingredients market in North America is projected to capture the largest market share by 2027 due to the higher demand for generic drugs, especially from the United States. Patent expiries of blockbuster drugs are also expected to contribute to market growth.
Sun Pharmaceuticals Industries, Ltd., Abbvie, Inc., Novartis, Eli Lilly and Company, Lonza Group AG, Merck & Co., Inc., Mylan N.V., Boehringer Ingelheim GmbH, Aurobindo Pharma, Teva Pharmaceutical Industries, Ltd., Bayer AG, Bristol-Myers Squibb, Albemarle Corporation, Cipla, and Dr. Reddy's Laboratories are the major companies operating in the region which have been profiled in the report.